Management strategies and possible risk factors for ventricular septal defects after transcatheter aortic valve replacement: Case series from a single center and review of literature.

Abstract

Development of membranous ventricular septal defects (VSD) is a rare complication of transcatheter aortic valve replacements (TAVR), and is recognized using intraoperative and postoperative imaging. We present two cases of this rare but serious complication; one was successfully managed conservatively and the other with valve-in-valve therapy. Management strategies for post-TAVR VSDs varies, but should be individualized to the clinical scenario. We performed a literature search and sought to identify various risk factors which may predispose patients to the development of VSD after TAVR.

• Authors: M Rizwan Sardar, Zubair A Khan, Anu Abraham, Wajeeha Saeed, Muhammad Farhan, Dhaval Kolte, Barry Sharaf, Paul Gordon, Frank Sellke, Neel R Sodha, Herbert D Aronow, Afshin Ehsan
• Journal: Cardiovascular revascularization medicine : including molecular interventions (Cardiovasc Revasc Med) Vol. 18 Issue 6 Pg. 462-470 (Sep 2017) ISSN: 1878-0938 [Electronic] United States
• PMID: 28455074 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2017 Elsevier Inc. All rights reserved.

Topics

• Aortic Valve (surgery)
• Aortic Valve Stenosis (surgery)
• Heart Septal Defects, Ventricular (surgery)
• Heart Valve Prosthesis (adverse effects)
• Humans
• Risk Factors
• Transcatheter Aortic Valve Replacement (methods)